Purpose: Mitral regurgitation (MR) grading by two-dimensional transthoracic echocardiography is challenging, but important to determine the best treatment strategy in patients with MR. Current guidelines advocate an integrative approach, although no recommendation is provided on how to do so. An easy-to-use index will be helpful for standardized and reproducible MR grading. Negative predictive value was 100% for score 0 and 1; score 6-8 showed a 100% positive predictive value. Inter-and intra-observer agreements were excellent (Kvalues >0.80).
| INTRODUCTION
Mitral regurgitation (MR) is frequently diagnosed, representing 32% of the native left-sided valve disease. 1 Its prevalence increases significantly with age; at present, nearly 10% of people over 75 years old have significant regurgitation of the mitral valve (MV). 2 Structural deficiencies in the MV apparatus (organic MR) or secondary changes induced by abnormal ventricular size and deformation (functional MR) contribute to the valvular regurgitation. 3, 4 The definitive therapy is usually surgical intervention, notwithstanding advances in catheterbased approaches. 5, 6 Surgery is indicated in patients with severe MR and symptoms, and timely intervention is pivotal to prevent complications including heart failure, arrhythmia, and sudden cardiac death.
Thus, it is of utmost importance to accurately determine the severity of MR. 3, [5] [6] [7] [8] Due to its relatively low costs and extensive availability, two-dimensional (2D) transthoracic echocardiography (TTE) still is the key imaging modality for diagnosing MR. However, differentiating moderate from severe MR remains challenging in the absence of a clear definition of the MR severity and its quantification. [9] [10] [11] Accurate quantification not only prevents undergrading of patients with identified severe MR as having nonsevere MR, 12 it also prevents referral of patients to surgical centers for severe MR by echocardiography that reveal nonsevere MR on advanced evaluation, for example, by transesophageal echocardiography (TEE) or cardiac magnetic resonance (CMR). 13 Unfortunately, a semiquantitative estimation of MR mainly based on visual analysis of jet characteristic is still used in daily practice, 7, 14 despite the fact that previous studies have shown the inaccuracy and lack of reproducibility of this method. [15] [16] [17] Quantitative assessment of MR, such as the proximal isovelocity surface area (PISA) method and calculation of the effective regurgitant orifice (ERO) area by 2D
and Doppler, avoids subjective interpretation and therefore is preferable. 5, 6, 9, 11, 18 Nevertheless, these methods are widely used as research tools, but sparsely applied in routine evaluation due to the time-consuming aspect, technical limitations, and operator dependency. [18] [19] [20] Recognized echocardiographic signs and corresponding cutoff values of MR severity are theoretically based, or known predictors of postoperative outcome in patients with severe MR. Given the different strengths and weaknesses of these individual methods to assess severity, the current guidelines recommend an integration of multiple echo parameters to incorporate advantages of each variable while limiting the effect of technical and measurement errors. It includes the evaluation of MV morphology, jet characteristics, vena contracta (VC) and related effective regurgitant orifice (ERO), regurgitant volume and/or fraction, MV inflow pattern, pulmonary venous inflow, systolic pulmonary artery pressure (SPAP), and left atrial and/ or ventricle consequences. 5, 6, 9, 11 However, no algorithm or recommendation is provided on how to do so. In our experience, physicians are aware of the additional value of an integrative approach, although they are limited by the lack of a practical tool to correctly interpret the echocardiographic results within an acceptable timeframe for daily practice.
In this retrospective study, we performed a cross-sectional analysis of the recommended echo parameters for MR grading in 145 patients to: (1) develop a practical scoring index to determine MR severity using the current guidelines (referred to as the ROSE-index: mitral RegurgitatiOn Severity grading by an Easy-to-use index), and (2) compare the ROSE-index with an expert's semiquantitative evaluation of MR severity (reference standard). We hypothesized that the ROSEindex will be more accurate and less time intensive than currently used grading methods, thereby stimulating the use of an integrative approach. This may improve MR grading for clinical decision making, follow-up, and research purposes.
| MATERIALS AND METHODS

| Study population
We retrospectively analyzed the 2DTTE data of 145 patients that were referred to the University Medical Center Utrecht for the evaluation of moderate or severe MR. Figure 1 depicts the flowchart of the study design.
| Echocardiographic examination
Standardized 2DTTE examination was performed in all subjects utilizing multiple parasternal and apical views with the patient in the left lateral position. Examinations were performed with Philips 5500 or Philips iE33 (Philips Medical Systems, Andover, MA, USA) echocardiography machines. All datasets were archived on the hospital server as video loops and freeze frames in a digital format (DICOM). Offline analysis was performed using Xcelera software. In our echo laboratory, the routine assessment of MR grade is performed by a member of the experienced team of sonographers, and supervised by the ex- Imaging (EACVI). 5, 6, 9, 11, 21, 22 In Online Resource 1 (Data S1), a detailed description of the echocardiographic examination methods is given.
| Total index score per patient
Cutoff values of the quantitative parameters (see Table 1 ) were used to score each parameter negative (0) or positive (1) for severe MR.
In three qualitative variables, the cutoff was based on a composite outcome of several subanalyses (each scored 0 or 1 for severe MR):
• MV morphology composed of the subparameters (1) flail leaflet, (2) papillary muscle rupture, (3) annular dilatation (end-diastolic diameter >3.5 cm), (4) tethering (positive for severe MR when tethering area >2.5 cm 2 and/or coaptation distance ≥1 cm), (5) rheumatic etiology, To assess the total ROSE-index score, each score per variable was multiplied by the contribution of that variable (indicated by the coefficients per variable after multivariable analysis).
| Statistical analysis
Statistical analysis was performed using SPSS software version 21.0 (SPSS, IBM Corporation, Armonk, NY, USA) and the R language environment (R Core Team 2015, version 3.2.1). Multiple imputation was performed using the Multivariate Imputation by Chained Equations (mice) package and modeling, internal validation, and calibration with the Regression Modeling Strategies (rms) package. 23, 24 All analyses in this study are according to the most recent reporting guidelines (TRIPOD statement). 25 Continues values were expressed as mean±SD and compared with the unpaired Student's t test for normally distributed data. Skewed variables were depicted as median with interquartile range (IQR), and compared using the Mann-Whitney U test.
Categorical data were described using frequencies and percentages, with comparative evaluations performed via the chi-square or Fisher's exact test. A two-tailed P-value <0.05 was regarded as statistically significant.
Missing data were considered at random and therefore eligible for multiple imputations. The mice package was used to create 20 imputed datasets. 23 The imputation procedure was performed with all predictors and the outcome used in the modeling steps included.
Using univariable and multivariable logistic regression, the coefficients (β's) and corresponding odds radios (ORs) with 95% confidence intervals (95% CIs) were calculated.
To obtain the ROSE-index, a backward stepwise approach was adopted starting with all 11 guideline based parameters included. 26 In Online Resource 2 (Data S1), a detailed description is given. For the calculation of the total ROSE-index score, the coefficients of the parameters that were retained in the final model were simplified by rounding them to their nearest integer. The total ROSE-index score per patient was used in a receiver operating characteristic (ROC) and twoby-two table analysis for assessing the best cutoff value to determine severe MR. Resulting predictive values were calculated. The observed and predicted probabilities of severe MR per patients were evaluated.
To test inter-observer variability, all images were analyzed by two and >0.80 were considered to represent slight, fair, moderate, substantial, and excellent agreement, respectively. 27 The hypothesis of equal median total ROSE-index score was tested by the Wilcoxon signed rank test, while the differences in MR severity were tested by the McNemar's test. Comparisons were considered significant in the presence of a P-value <0.05.
| RESULTS
| Patient characteristics
Based on our reference standard, 80 (55%) subjects were classified as having severe MR and 65 (45%) as having moderate MR. Baseline characteristics are depicted in 
| Determination and scoring of parameters
We were able to score a median of 9.0 (IQR 8.0-10.0) parameters per patient of the 11 parameters as recommended by the guidelines. T
Parameter Cutoff values based on the guidelines Predictive of severe MR in case of: annular dilatation, flail leaflet, papillary muscle rupture, large tethering area or coaptation distance, rheumatic etiology, cleft (visual discontinuity of the leaflet from the free edge of the mitral ring, resulting in regurgitation), and (previous) endocarditis. b Including both central and eccentric (impinging on the lateral wall or the interatrial septum) jets, and predictive of severe MR in case of: swirling type, reaching the left atrial posterior wall, and jet to left atrial surface ratio >40%. 
| Logistic regression model
Each of the echocardiographic parameters was used as an univariate predictor of severe MR. In Table 4 , these parameters are depicted with corrected OR's that remained significant predictors (P-value<0. 25) for severe MR after multivariable analysis, including their simplified coefficients (corrected with a shrinkage factor of 0.82 after internal validation, and rounded to their nearest integer). Multiple regressions showed that the following variables need to be evaluated for reliable MR grading: MV morphology, jet characteristics, VC, SR, and LV dimensions. The ROSE-index score was calculated by adding the value for each of these individual parameters following the formula:
ROSE-index score=(valve morphology*1)+(jet characteristics*2)+(vena contracta*2)+(systolic reversal*2)+(LV dimensions*1). The maximum score was 8 based on the five parameters with corresponding coefficients. The final model is also shown in Online Resource 4 (Data S1).
| Internal validation and predictive values
Based on the implemented data, there was a significant difference (P<0.0001) in median total ROSE-index score for moderate vs severe MR (based on the most optimal imputed database, see Figure 2 ). The discriminative ability (of all 20 imputed datasets) showed a pooled C-statistic of 0.91, and shrinkage factor of 0.85. The calibration of the ROSE-index revealed no apparent over-or underestimation at the entire range of predicted probabilities (Figure 3) . ROC-analysis of the total ROSE-index score per patient (based on the most optimal implemented dataset) showed a best cutoff score of ≥4 to determine severe MR with sensitivity 0.84, specificity 0.83, positive predictive value 0.86, and negative predictive value 0.81 (Table 5) . A score of 0 or 1 was always related to nonsevere MR (100% NPV), whereas a score of ≥6 was only seen in patients with severe MR (100% PPV) (Figure 2) . One of three patients that showed score 2 or 3 was diagnosed with severe MR (observed predicted probability 32%, calculated probability 28%). The number of patients with score 2 or 3 was 41 (28%).
| Inter-observer and intra-observer variability
Inter-observer variability showed an excellent agreement between both observers regarding the clinical diagnosis (K=0.86, 95% CI 0.82-0.90), with no significant inter-observer variability (P=0.75). In 10 patients (6.9%), there was a change in clinical diagnosis when comparing the results of observer 1 and 2. Median (IQR) total ROSE-index score did not significantly differ between both observers (both median score 
| DISCUSSION
In the present study, an easy-to-use scoring index was determined and validated based on daily clinical echocardiograms of moderate or severe MR, which (1) correctly determined MR severity in 83% using only five of the 11 echocardiographic parameters as recommended by the current guidelines, and (2) proved to be reliable and reproducible. This so-called ROSE-index can serve as an easy-to-use tool for integrated analysis of guideline parameters, and thus aid both clinicians and researchers to determine MR severity.
| The MR severity model
Based on a two-by-two table revealing the lowest percentage of patients that were misdiagnosed by the ROSE-index (Table 5) , a cutoff score ≥4 was considered to indicate severe MR. Of the patients with F I G U R E 2 Box plots (dark grey color) of the total ROSE-index score (vertical axis) in moderate (n=65) and severe (n=80) mitral regurgitation patients (based on the most optimal imputed database). The 100% positive predictive value (PPV, score>5) and 100% negative predictive value (NPV, score<2) are depicted in the light gray color. The median (IQR) total score in moderate mitral regurgitation is 2.0 (0.5-3.0), and in severe mitral regurgitation 5.0 (4.0-7.0), P<0.0001 score <4, only scores 0 or 1 were always related to moderate MR, whereas patients with index score 2 or 3 had, respectively, a 22% and 38% calculated predicted probability to be misdiagnosed. Awareness in these subjects is recommended, and extra evaluation using stress echocardiography or CMR imaging may be of additional value to unveil the true severity. Among patients with score ≥4, 14% were classified incorrectly. However, due to pre-operative diagnostics (TEE, evaluation in a heart valve team), we expect these misclassified patients will be correctly reclassified in a later phase, as is currently also the case in daily practice in often a higher percentage of patients.
| Parameters in the index
The parameters MV morphology and LV dimensions were frequently scored (>90%) in our study, and they are known to be related to the clinical outcome of patients with MR. 28, 29 However, their poor specificity for severe MR results in a lower contribution of these parameters to the ROSE-index. VC was the only quantitative measurement included in the scientific index after regression analysis. Despite the technical difficulties in obtaining VC, 30 it was determined in 86% of the study population with high specificity (negative score in >90% of patients with moderate MR). This confirms the concept that the VC is less susceptible to physiologic loading conditions, hence may be more feasible, accurate, and appropriate as screening tool. [30] [31] [32] In particular, the quantitative ERO measurement was sparsely evaluated.
Our data therefore confirm that this parameter has not been widely accepted as a part of routine echo examination, due to its known limitations. [18] [19] [20] One would expect regurgitant volume (calculated using the PISA method) to be under-evaluated as well; however, assessment can also be performed using standardized methods for calculation of flow. Nevertheless, both parameters were not significantly related to the MR severity in our multivariable analysis. Thus, despite studies revealing validity and utility of ERO and related parameters in a research setting, 33, 34 our study confirms the results showing variable feasibility in a clinical setting. 20, 35, 36 As in the study of Quader et al., 37 we showed that E-wave velocity was not sensitive enough to exclude severe MR, therefore not useful as a screening tool. Regarding the qualitative measurements, both jet characteristics and SR contributed more to the final score. In accordance with previous studies, color flow imaging was highly sensitive and therefore of value despite its low specificity. 15, 19, 38 The systolic flow reversal was important due to its known high specificity rate. 
| Reproducibility
The inter-and intra-observer variability for both clinical diagnosis and ROSE-index score showed an excellent agreement. A change in clinical diagnosis was seen in 6.9% of the patients when comparing results of observer 1 vs 2. As would happen in clinical practice, consensus reading was performed in these 10 cases that the observers disagreed on, resulting in a final revised change of clinical diagnosis in 3% of the patients. Reason for MR severity revision was most often due to poor echo images. As this reflects daily practice, the index is useful for clinical decision making, as consensus reading is usually implemented in most cardiology practices.
| Previous scoring indexes
Two earlier studies in literature used a scoring index based on the guidelines. 36, 40 In the retrospective study of Thomas et al., 40 MR grading was performed using six echo parameters that were frequently applied. Although the authors stated their MR Index may be easy to use, it included three quantitative measurements (PISA, SPAP, LA dimension), and the venous flow pattern parameter; all known to be more difficult to apply. Moreover, each parameter was scored on a difficult four-point scale. The reference standards used were the qualitative grading by an expert and the regurgitant fraction. In contrast, we used expert reading as a reference standard as it is most frequently used and previously proved reliable. 8, 40, 41 Regurgitant fraction was excluded in our study due to technical issues in a retrospective study.
Our index is superior for distinguishing moderate from severe MR, however, almost all patients had MR grade ≤3.
A few other articles described algorithms for distinguishing severe from nonsevere MR, although none of these step-by-step approaches were analyzed in a retrospective or prospective study.
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| Clinical implications
Current practice for the management of MR is aimed at early detection and reliable surveillance of significant MR. Our five-parameter ROSE-index may aid the treating physician how to use the integrated approach as recommended by the guidelines. 5, 6 Scores 0 and 1 always indicate moderate MR; score ≥4 is related to severe MR.
Patients with index score 2 or 3 need evaluation in a heart valve team, 45 and cross-checking with the clinical assessment and hemodynamic consequences, for example, by stress echocardiography remains important. 46 ,47 Furthermore, we foresee three-dimensional (3D) echocardiography and/or CMR imaging techniques to gain a more important role in MR grading in the nearby future, although technical limitations and time-consuming processing still prevent it from becoming widely adopted into daily practice at the present. 44 ,48,49
| Limitations
This concerns a retrospective study with its inherent limitations. As the reference standard, we used semiqualitative echocardiographic grading by an expert panel. Although this has been previously used as a reference standard and proved reliable in other studies, 8, 40, 41 the evaluation by various experts is difficult to standardize and may cause variability in classification. Furthermore, only patients with moderate or severe MR were evaluated, and consequently, our findings may not be extrapolated to lower grades of MR severity. Also the exact value of the ROSE-index score in patients with AF needs to be further investigated. Finally, the utility of our current scoring index needs further validation in prospective and longitudinal studies.
| CONCLUSION
Our semiquantitative ROSE-index is an easy-to-use scoring index to determine severity of mitral regurgitation by two-dimensional transthoracic echocardiography in clinical practice and for research purposes. In contrast to current guideline recommendations involving 11 parameters, this five-parameter grading index is relatively simple and less time-consuming without a loss of accuracy. Consensus reading in a multidisciplinary heart valve team, with cross-checking against the hemodynamic consequences of mitral regurgitation, remains necessary in one of four patients.
